Related references
Note: Only part of the references are listed.Cytochromes P450: Roles in Diseases
Irina A. Pikuleva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Induction of Hepatic CYP3A Enzymes by Pregnancy-Related Hormones: Studies in Human Hepatocytes and Hepatic Cell Lines
Ioannis Papageorgiou et al.
DRUG METABOLISM AND DISPOSITION (2013)
Isoform-Specific Regulation of Cytochromes P450 Expression by Estradiol and Progesterone
Su-Young Choi et al.
DRUG METABOLISM AND DISPOSITION (2013)
Inhibition of Human Steroidogenic Cytochrome P450 c17 by 21-Hydroxypregnenolone and Related Steroid Hormones
Toshiro Niwa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Diversity and Substrate Specificity in the Structures of Steroidogenic Cytochrome P450 Enzymes
Hiroshi Sugimoto et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Comparison of Cytochrome P450 2C Subfamily Members in Terms of Drug Oxidation Rates and Substrate Inhibition
Toshiro Niwa et al.
CURRENT DRUG METABOLISM (2012)
Comparison of CYP3A4 and CYP3A5: The Effects of Cytochrome b5 and NADPH-cytochrome P450 Reductase on Testosterone Hydroxylation Activities
Su-Jun Lee et al.
DRUG METABOLISM AND PHARMACOKINETICS (2012)
Oxidation of Dihydrotestosterone by Human Cytochromes P450 19A1 and 3A4
Qian Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Role of a Disordered Steroid Metabolome in the Elucidation of Sterol and Steroid Biosynthesis
Cedric H. L. Shackleton
LIPIDS (2012)
4β-hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans
Ulf Diczfalusy et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Evaluation of 6β-Hydroxycortisol, 6β-Hydroxycortisone, and a Combination of the Two as Endogenous Probes for Inhibition of CYP3A4 In Vivo
C-C Peng et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Comparison of Cytochrome P450 2D6 and Variants in Terms of Drug Oxidation Rates and Substrate Inhibition
Toshiro Niwa et al.
CURRENT DRUG METABOLISM (2011)
Steroid Regulation of Drug-Metabolizing Cytochromes P450
Katalin Monostory et al.
CURRENT DRUG METABOLISM (2011)
Inhibition of Human Cytochrome P450 3A4 by Cholesterol
Raku Shinkyo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Still another activity by the highly promiscuous enzyme CYP3A4: 25-hydroxylation of cholesterol
Ulf Diczfalusy et al.
JOURNAL OF LIPID RESEARCH (2011)
Cholesterol 25-hydroxylation activity of CYP3A
Akira Honda et al.
JOURNAL OF LIPID RESEARCH (2011)
16α-Hydroxyprogesterone: Origin, biosynthesis and receptor interaction
Karl-Heinz Storbeck et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Kinetic Analysis of the Three-step Steroid Aromatase Reaction of Human Cytochrome P450 19A1
Christal D. Sohl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Comparison of the Contributions of Cytochromes P450 3A4 and 3A5 in Drug Oxidation Rates and Substrate Inhibition
Toshiro Niwa et al.
JOURNAL OF HEALTH SCIENCE (2010)
Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase
Vishal Agrawal et al.
PHARMACOGENETICS AND GENOMICS (2010)
4 beta-Hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after induction with rifampicin
Ulf Diczfalusy et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Oxidation of Endobiotics Mediated by Xenobiotic-Metabolizing Forms of Human Cytochrome P450
Toshiro Niwa et al.
CURRENT DRUG METABOLISM (2009)
Extraadrenal 21-Hydroxylation by CYP2C19 and CYP3A4: Effect on 21-Hydroxylase Deficiency
Larissa G. Gomes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Effect of psychotropic drugs on the 21-hydroxylation of neurosteroids, progesterone and allopregnanolone, catalyzed by rat CYP2D4 and human CYP2D6 in the brain
Toshiro Niwa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Heterotropic cooperativity in oxidation mediated by cytochrome P450
Toshiro Niwa et al.
CURRENT DRUG METABOLISM (2008)
Identification of human hepatic cytochrome P450 enzymes involved in the biotransformation of cholic and chenodeoxycholic acid
Anand K. Deo et al.
DRUG METABOLISM AND DISPOSITION (2008)
Defective Activity of Recombinant Cytochromes P450 3A4.2 and 3A4.16 in Oxidation of Midazolam, Nifedipine, and Testosterone
Mitsue Miyazaki et al.
DRUG METABOLISM AND DISPOSITION (2008)
Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptor
Krisztina Kohalmy et al.
DRUG METABOLISM AND DISPOSITION (2007)
Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition
Fang Lu et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Comparison of the 17 alpha-hydroxylase/C17,20-lyase activities of porcine, guinea pig and bovine P450c17 using purified recombinant fusion proteins containing P450c17 linked to NADPH-P450 reductase
Manjunath S. Shet et al.
DRUG METABOLISM REVIEWS (2007)
Cytochrome P450s and cholesterol homeostasis
Irina A. Pikuleva
PHARMACOLOGY & THERAPEUTICS (2006)
Inhibition of the human liver microsomal and human cytochrome P450 1A2 and 3A4 metabolism of estradiol by deployment-related and other chemicals
Khawja A. Usmani et al.
DRUG METABOLISM AND DISPOSITION (2006)
Cholesterol-metabolizing cytochromes P450
IA Pikuleva
DRUG METABOLISM AND DISPOSITION (2006)
Role of polymorphic human cytochrome P450 enzymes in estrone oxidation
AE Cribb et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Characterization of testosterone 11β-hydroxylation catalyzed by human liver microsomal cytochromes P450
MH Choi et al.
DRUG METABOLISM AND DISPOSITION (2005)
A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio
V Paracchini et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2005)
Characterization of stable human aromatase expressed in E-coli
N Kagawa et al.
STEROIDS (2004)
Stereo- and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450
KKM Miller et al.
DRUG METABOLISM AND DISPOSITION (2004)
Cytochrome P450 2D catalyze steroid 21-hydroxylation in the brain
W Kishimoto et al.
ENDOCRINOLOGY (2004)
Effect of genetic polymorphism on the metabolism of endogenous neuroactive substances, progesterone and p-tyramine, catalyzed by CYP2D6
T Niwa et al.
MOLECULAR BRAIN RESEARCH (2004)
Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells
J Russo et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Structure/function relationships responsible for coenzyme specificity and the isomerase activity of human type 1 3β-hydroxysteroid dehydrogenase/isomerase
JL Thomas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Characterization of the oxidative metabolites of 17β-estradiol and estrone formed by 15 selectively expressed human cytochrome P450 isoforms
AJ Lee et al.
ENDOCRINOLOGY (2003)
The 17, 20-lyase activity of cytochrome p450c17 from human fetal testis favors the Δ5 steroidogenic pathway
CE Flück et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
In vitro activation of 7-benzyloxyresorufin O-debenzylation and nifedipine oxidation in human liver microsomes
T Niwa et al.
XENOBIOTICA (2003)
CYP3A4 and CYP3A7-mediated carbamazepine 10,11-epoxidation are activated by differential endogenous steroids
H Nakamura et al.
DRUG METABOLISM AND DISPOSITION (2003)
New aspects on primary aldosteronism
U Enberg et al.
NEUROCHEMICAL RESEARCH (2003)
Developmental expression of the major human hepatic CYP3A enzymes
JC Stevens et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7
JA Williams et al.
DRUG METABOLISM AND DISPOSITION (2002)
Amino acid residues affecting the activities of human cytochrome P4502C9 and 2C19
T Niwa et al.
DRUG METABOLISM AND DISPOSITION (2002)
Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes
H Nakamura et al.
DRUG METABOLISM AND DISPOSITION (2002)
Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli
H Yamazaki et al.
PROTEIN EXPRESSION AND PURIFICATION (2002)
Summary of information on human CYP enzymes: Human P450 metabolism data
S Rendic
DRUG METABOLISM REVIEWS (2002)
Effect of two mutations of human CYP1B1, G61E and R469W, on stability and endogenous steroid substrate metabolism
I Jansson et al.
PHARMACOGENETICS (2001)
Role of human cytochrome P450 1A1, IA2, 1B1, and 3A4 in the 2-, 4-, and 16α-hydroxylation of 17β-estradiol
AF Badawi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
Allelic variants of human cytochrome P450 1A1 (CYP1A1): effect of T461N and I462V substitutions on steroid hydroxylase specificity
D Schwarz et al.
PHARMACOGENETICS (2000)
Share Paper
